MoneyWorks4Me

Orchid Pharma informs about closure of trading window

18 May 2016 Evaluate

Orchid Pharma has informed that a meeting of the Board of Directors is proposed to be held on May 27, 2016, to approve the Audited financial results of the Company for the period from April 01, 2015 to March 31, 2016. As required under the SEBI (Prohibition of Insider Trading) Regulations, the trading window for dealing in the securities of the Company shall remain closed for all the Insiders from May 18, 2016 to May 30, 2016.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1852.50
Dr. Reddys Labs. 1146.30
Cipla 1360.10
Lupin 2047.00
Zydus Lifesciences 1108.50
View more..